ID:2908 First-Line Nivolumab + Ipilimumab vs Chemotherapy in Unresectable Malignant Pleural Mesothelioma: CheckMate 743

Authors

Keywords

Journal

Volume 15, Issue 10, Pages e42

Publisher

Elsevier BV

Online

2020-09-10

DOI

10.1016/j.jtho.2020.08.004

Discuss science. Find collaborators. Network.

Join a conversation

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started